Page URL: https://www.bionews.org.uk/0421
CONTENTS Issue #421
COMMENT
Infertility treatment and the welfare of the child
NEWS DIGEST
REVIEWS
BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read

You are currently viewing the Alert version of the BioNews email newsletter.

Click the tab above to view the Full Text version

Welcome to BioNews by email, published by the Progress Educational Trust, providing you with news, comment and reviews on genetics, assisted conception, embryo/stem cell research and related areas. 


Visit the BioNews website at www.bionews.org.uk where you can subscribe for free to receive BioNews by email in one of three formats, and search the archive of more than 8,000 articles.

Infertility treatment and the welfare of the child
20 August 2007 - by Professor Eric Blyth
The UK was one of the first jurisdictions to introduce comprehensive legislation regulating fertility treatment. Since the issues and practices regulated by the Human Fertilisation and Embryology (HFE) Act were - and remain - contentious, it is hardly surprising that the Act itself has been controversial. Section 13(5) of the Act... [Read More]
Lights in fertility clinics may damage embryos
20 August 2007 - by MacKenna Roberts
A study has found that exposure to the 'harsh' cool-white fluorescent lighting commonly used in fertility clinics, research labs and most office environments could be particularly damaging to an embryo's healthy development. A joint team of researchers in Hawaii and Japan conducted the study on mouse embryos... [Read More]
NHS IVF treatment may offer lower chance of success than private clinics
20 August 2007 - by Danielle Hamm
A BBC investigation has found that women receiving IVF on the National Health Service (NHS) in the UK may have a lower chance of conceiving than private patients because treatment is not always provided at the most appropriate time. There is an optimal time to perform the... [Read More]
Gene therapy trial death under investigation
20 August 2007 - by Ailsa Stevens
Last month a gene therapy trial for arthritis, carried out by US company Targeted Genetics, was halted when following the death of 36-year-old participant Jolee Mohr. Although the exact cause of her death is still unknown, the usually mild fungal infection found throughout Mrs Mohr's body... [Read More]
US FDA  to subject blood-thinning drug to genetic test
20 August 2007 - by Stuart Scott
In the first move of its kind, the US Food and Drug Administration (FDA) - the agency responsible for regulating food, drugs and biological medical products - has recommended a genetic test prior to the prescription of a drug, Warfarin, in order to gauge potential patient response. Warfarin, sold... [Read More]
IVF women prefer risky pregnancy to no pregnancy
20 August 2007 - by Ailsa Stevens
Women with fertility problems would rather take the risks associated with multiple pregnancies than risk not becoming pregnant at all, reveals research published in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG) this month. Researchers from the University of Aberdeen surveyed a total of 74 women... [Read More]

Advertising in BioNews

BioNews is read by around 18,000 people every week. Our readership is predominantly in the UK, but we have subscribers in 44 countries. That is a lot of people with an interest in assisted conception, genetics, embryo/stem cell research and related areas.

Advertisements (up to 300 words in length) start from as little as £75, making BioNews a very cost effective way to reach your target audience.

The Progress Educational Trust can personally vouch for the service, as the charity has itself successfully engaged members of staff via BioNews. Why not save money by recruiting through BioNews, and help keep BioNews FREE at the same time?

If you would like further information about advertising a job or opportunity in BioNews, please contact Sarah Norcross on +44 (0)20 7278 7870 or at snorcross@progress.org.uk

Sarah Norcross
Director, Progress Educational Trust
140 Gray's Inn Road
London, WC1X 8AX